Kristopher K. Frese - Concepedia

Author

Kristopher K. Frese

Cancer Research UK Manchester Institute ORCID

Also Known As

Hui Sun Leong, K Frese, K K Frese, K. Frese, K.K. Frese, Kristopher Frese, Kristopher K Frese, Kristopher K. Frese, Kristopher K.* Frese

Publications

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute Cancer Research UK University of Manchester The Christie NHS Foundation Trust CRUK Lung Cancer Centre of Excellence

About

Kristopher K. Frese is an author at Cancer Research UK Manchester Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	6.1K
2	Cell Biology	7	7	5.8K
3	Health Sciences	1	1	161
4	Natural Sciences	1	1	34
5	Cellular Physiology	1	1	86

Kristopher K. Frese

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer Kenneth P. Olive, Michael A. Jacobetz, Christian J. Davidson, Science Tumor BiologyOncologyPancreatic CancerMedicinePharmacology	2009	3.1K
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Gina M. DeNicola, Florian A. Karreth, Timothy J. Humpton, Nature Oncogenic AgentOncogene-induced Nrf2 TranscriptionReactive Oxygen SpecieMedicineCell Biology	2011	2.2K
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer Kristopher K. Frese, Tashinga E. Bapiro, Tomoaki Nakagawa, Proceedings of the National Academy of Sciences Tumor BiologyPancreatic CancerMedicineImmunologyTreatment Response	2013	237
A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity Kathryn Simpson, Ruth Stoney, Kristopher K. Frese, Nature Cancer Intratumoral Phenotypic HeterogeneityTumor HeterogeneityMedicineCancer GenomicsBronchial Neoplasm	2020	161
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer Alice Lallo, Kristopher K. Frese, Christopher J. Morrow, Clinical Cancer Research	2018	155
C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D Florian A. Karreth, Kristopher K. Frese, Gina M. DeNicola, Cancer Discovery PathologyRas OncogenesisCancer BiologyTumor BiologyOncology	2011	144
cfDNA methylome profiling for detection and subtyping of small cell lung cancers Francesca Chemi, Simon P. Pearce, Alexandra Clipson, Nature Cancer	2022	129
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models Terrence F. Meehan, Nathalie Conte, Theodore C. Goldstein, Cancer Research	2017	127
Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein Kristopher K. Frese, Siu Sylvia Lee, Darby L. Thomas, Oncogene Adenovirus E4-orf1 OncoproteinSignal TransductionSignaling PathwayReceptor Tyrosine KinaseImmunology	2003	94
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study Christopher J. Morrow, F. Trapani, Robert Metcalf, Annals of Oncology	2016	93

Page 1